Multiple entities and individuals associated with Column Group have recently executed significant sales of Tenaya Therapeutics, Inc. (TNYA) shares. On February 25, 2026, Column Group Opportunity III GP, LP, Column Group III GP, LP, and Column Group III, LP each sold 1,649,281 shares, with transactions totaling approximately $923,597 per entity.
Additionally, on the same date, Tim Kutzkey sold 1,649,281 shares for approximately $923,597, and also sold 1,862,545 shares for approximately $1,043,025. Peter Svennilson also sold 1,862,545 shares at $0.56 per share, totaling $1,043,025. These sales represent a notable divestment from the biotechnology company.
While the provided data indicates multiple sales from entities and individuals linked to the Column Group, insider selling can occur for a variety of reasons, including portfolio diversification or tax planning, and does not necessarily reflect a negative outlook on the company's future prospects.